Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. ProMIS Neurosciences, Inc.
  6. News
  7. Summary
    PMN   CA74346M1095

PROMIS NEUROSCIENCES, INC.

(PMN)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ProMIS Neurosciences Brief: Says Shareholders Approved Special Resolution On Share Consolidation Relating to a Listing of Its Shares On a Stock Exchange in the U.S.

12/02/2021 | 07:20am EST


ę MT Newswires 2021
All news about PROMIS NEUROSCIENCES, INC.
01/18ProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy, Recruits Sci..
MT
01/18PRESSWIRE GLOBAL NEWS DISTRIBUTION : ProMIS Neurosciences Announces Antibody Program for S..
AQ
01/18ProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy and Recruitme..
GL
01/18ProMIS Neurosciences, Inc. Initiates Program to Develop Monoclonal Antibodies to Treat ..
CI
01/18ProMIS Neurosciences, Inc. Appoints Carsten Korth to its Scientific Advisory Board
CI
01/10PROMIS NEUROSCIENCES TO PARTICIPATE : Aduhelm Stimulating the Next Generation of Alzheime..
AQ
01/07PRESSWIRE GLOBAL NEWS DISTRIBUTION : ProMIS Neurosciences to Participate in the Biotech Sh..
AQ
01/07PROMIS NEUROSCIENCES TO PARTICIPATE : Aduhelm Stimulating the Next Generation of Alzheime..
AQ
01/06ProMIS Neurosciences to Participate in H.C. Wainwright BioConnect 2022 Virtual Conferen..
AQ
2021ProMIS Neurosciences Issues Chairman's Memorandum
AQ
More news
Financials
Sales 2020 0,00 M 0,00 M 0,00 M
Net income 2020 -5,66 M -4,50 M -4,50 M
Net cash 2020 1,07 M 0,85 M 0,85 M
P/E ratio 2020 -3,96x
Yield 2020 -
Capitalization 56,1 M 44,8 M 44,6 M
EV / Sales 2019 37 534x
EV / Sales 2020 15 614x
Nbr of Employees -
Free-Float 95,1%
Chart PROMIS NEUROSCIENCES, INC.
Duration : Period :
ProMIS Neurosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROMIS NEUROSCIENCES, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Managers and Directors
Eugene Williams Chairman & Chief Executive Officer
Elliot Goldstein President & Director
Daniel E. Geffken Chief Financial Officer
Neil R. Cashman Director & Chief Scientific Officer
Gavin T. Malenfant Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
PROMIS NEUROSCIENCES, INC.-10.34%45
GILEAD SCIENCES, INC.-5.65%85 938
REGENERON PHARMACEUTICALS-2.71%64 971
VERTEX PHARMACEUTICALS3.86%57 990
WUXI APPTEC CO., LTD.-9.18%49 645
BIONTECH SE-42.79%35 624